Isabel
Iriepa Canalda
Profesor/a Titular Universidad
Universidad Autónoma de Madrid
Madrid, EspañaPublicacións en colaboración con investigadores/as de Universidad Autónoma de Madrid (8)
2022
-
Polyfunctionalized α-Phenyl-tert-butyl(benzyl)nitrones: Multifunctional Antioxidants for Stroke Treatment
Antioxidants, Vol. 11, Núm. 9
2019
-
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer’s disease therapy
Journal of Enzyme Inhibition and Medicinal Chemistry, Vol. 34, Núm. 1, pp. 479-489
-
New Dual Small Molecules for Alzheimer's Disease Therapy Combining Histamine H3 Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition
Journal of Medicinal Chemistry, Vol. 62, Núm. 24, pp. 11416-11422
-
Quinoxalinetacrine QT78, a cholinesterase inhibitor as a potential ligand for Alzheimer’s disease therapy
Molecules, Vol. 24, Núm. 8
2011
-
Chemical and pharmacological studies on enantiomerically pure p-methoxytacripyrines, promising multi-target-directed ligands for the treatment of Alzheimer's disease
ChemMedChem, Vol. 6, Núm. 11, pp. 1990-1997
-
Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analogues
European Journal of Medicinal Chemistry, Vol. 46, Núm. 12, pp. 6119-6130
2010
-
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivatives
Journal of Medicinal Chemistry, Vol. 53, Núm. 14, pp. 5129-5143
1995
-
Synthesis and structural, conformational, biochemical, and pharmacological study of new compounds derived from tropane‐3‐spiro4′(5′)‐imidazoline as potential 5‐HT3 receptor antagonists
Journal of Pharmaceutical Sciences, Vol. 84, Núm. 1, pp. 101-106